The global single use assemblies market is set for robust expansion, with its valuation projected to grow from USD 18.7 billion in 2025 to USD 32.5 billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 5.7% over the forecast period from 2025 to 2035. The surge is primarily driven by increasing demand for cost-effective and contamination-free solutions in biopharmaceutical manufacturing, rising adoption of single-use technologies to accelerate production timelines, and stringent regulatory requirements for sterile processing. As the biopharma industry scales up biologic drug development, single-use assemblies—comprising disposable tubing, connectors, bags, and filters—are becoming essential for reducing cross-contamination risks and enhancing flexibility. This market evolution is further fueled by innovations in modular designs and sustainable materials, positioning single-use assemblies as key enablers in efficient, scalable bioprocessing.
Market Segmentation and Trends
The single-use assemblies market is segmented by component, application, end user, and region, providing a detailed understanding of its dynamics. By component, segments include bags, tubing, connectors, filters, and others, with bags leading due to their role in fluid storage and transfer. By application, categories encompass mixing systems, filtration, storage, and filling, where filtration dominates for its critical role in purification processes.
By end user, the market covers biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutions, with biopharmaceutical companies holding the largest share. Regionally, North America leads with advanced biopharma infrastructure, while Asia Pacific is the fastest-growing, driven by emerging manufacturing hubs in China and India.
Market trends include the adoption of gamma-sterilized assemblies for aseptic processing, integration of RFID for track-and-trace capabilities, and a shift towards bio-based plastics for sustainability. The market is also seeing growth in customizable, pre-sterilized kits to streamline workflows and reduce setup times.
Full Market Report Available for Delivery. For Purchase or Customization, Please Request Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=7816
Driving Factors Behind Market Growth
The single-use assemblies market is propelled by several key drivers. The rising production of biologics and biosimilars necessitates flexible, contamination-free systems, accelerating adoption in upstream and downstream processes. Cost savings from reduced cleaning and validation requirements compared to stainless steel systems support market expansion.
Stringent regulatory guidelines from FDA and EMA emphasize sterile manufacturing, boosting demand for disposable solutions. The growth of CDMOs and contract manufacturing further drives scalability needs. Additionally, sustainability initiatives promote recyclable single-use components, aligning with global environmental goals.
Recent Developments and Key Players
The single-use assemblies market is competitive, with key players focusing on innovation, quality assurance, and strategic partnerships. Recent developments include March 2025: Sartorius launched a new line of single-use bioreactors with integrated assemblies, enhancing scalability for small-batch production. January 2025: Thermo Fisher Scientific acquired a bioprocessing startup to bolster its single-use portfolio.
Key players include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, GEA Group AG, Pall Corporation, GE Healthcare, and Bio-Rad Laboratories Inc. Competitor analysis reveals a emphasis on R&D for leak-proof connectors and sustainable materials. Companies are investing in pre-sterilized kits and forming alliances with CDMOs to expand market reach.
Regional Insights and Opportunities
North America dominates the single-use assemblies market, driven by leading biopharma hubs in the U.S., with a focus on biologics innovation. Europe follows, with Germany and Switzerland emphasizing regulatory compliance and advanced manufacturing.
Asia Pacific is the fastest-growing region, led by China at a 6.5% CAGR, fueled by CDMOs and vaccine production. India offers opportunities through affordable bioprocessing. Latin America and the Middle East & Africa present potential via emerging biotech sectors. Partnerships with local manufacturers are key to tapping these markets.
Challenges and Future Outlook
The market faces challenges, including concerns over plastic waste and leachables/extractables, high initial costs for custom assemblies, and supply chain vulnerabilities for raw materials. However, the future outlook is positive, with opportunities in sustainable bio-based assemblies and modular designs. As biopharma scales, the market is well-positioned for sustained growth through 2035.
Check out More Related Studies Published by Fact.MR:
Single Photon Emission Computed Tomography (SPECT) Market
Single-Lead ECG Monitor Market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: [email protected]
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
